• The transaction involves the entry of new national and international investors and has been subscribed by several of its core shareholders

Atrys Health, S.A. (ATRY), a global provider of precision medical diagnostic and treatment services and a pioneer in state-of-the-art telemedicine and radiotherapy, announces the successful completion of a capital increase aimed at qualified investors valued at 72 million euros, which also represents the entry of several family offices and international investors.

In order to finance the recent acquisition of the medical oncology company Bienzobas, the Board of Directors of Atrys agreed to a capital increase with cash contributions and excluding pre-emptive subscription rights at EUR 7.00 per share, of which EUR 0.01 corresponds to the nominal value and EUR 6.99 to the share premium. As a result of the capital increase, Atrys will issue 10,350,000 new shares.

In addition to new Spanish family offices, Atrys’ main shareholders, such as Onchena, Mayoral and Caser, as well as the company’s own management team, have also joined the company.

For Santiago de Torres, Chairman of Atrys, “this capital increase highlights the attractiveness of our company after jumping to the Main Market and confirms the interest of both national and international investors to join us in our ambitious growth plan. We are very satisfied with the operation and we are especially grateful for the support of the investors who were already with us and who have now increased their participation”.

Atrys will apply for admission to trading of the new shares on the Madrid, Barcelona, Bilbao and Valencia Stock Exchanges, as well as their inclusion in the Spanish Stock Exchange Interconnection System (SIBE). The shares are expected to be admitted to trading on 15 June, and start trading throughout the week.

The placement of the new shares has been carried out through an accelerated private placement procedure undertaken by Barclays Bank Ireland, Andbank España, Banco de Sabadell, GVC Gaesco Valores and Renta 4 Banco. Mediobanca – Banca di Credito Finanziario S.p.A. has acted as financial advisor to the company. Linklaters has acted as legal advisor to the underwriters, and Gómez-Acebo & Pombo Abogados as legal advisor to Atrys.